{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:47:46Z","timestamp":1762609666449},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12029-024-01019-5","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T15:03:49Z","timestamp":1705590229000},"page":"759-767","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Simultaneous Integrated Boost (SIB) Versus Sequential Boost in Anal Cancer Patients: A Single-Center Experience"],"prefix":"10.1007","volume":"55","author":[{"given":"Divya","family":"Khosla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Treshita","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divyesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun Singh","family":"Oinam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surinder Singh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhosh","family":"Irrinki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Madan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"issue":"6","key":"1019_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, et al. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial. Lancet Oncol. 2013;14(6):516\u201324.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1019_CR2","first-page":"1943","volume":"36","author":"P Franco","year":"2016","unstructured":"Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Rondi N, et al. Early-stage node-negative (t1\u2013t2n0) anal cancer treated with simultaneous integrated boost radiotherapy and concurrent chemotherapy. Anticancer Res. 2016;36(4):1943\u20138.","journal-title":"Anticancer Res"},{"key":"1019_CR3","unstructured":"Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Rondi N, et al. Locally advanced (t3-t4 or n+) anal cancer treated with simultaneous integrated boost radiotherapy and concurrent chemotherapy. Anticancer Res. 2016;36(4):2027\u201332."},{"key":"1019_CR4","doi-asserted-by":"crossref","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB, Thomas CR, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal a randomized controlled trial. JAMA. 2008;299(6):1914\u201321.","DOI":"10.1001\/jama.299.16.1914"},{"issue":"3","key":"1019_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0360-3016(01)01510-3","volume":"50","author":"DC Weber","year":"2001","unstructured":"Weber DC, Kurtz JM, Allal AS. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys. 2001;50(3):675\u201380.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1019_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12094-016-1504-2","volume":"19","author":"P Franco","year":"2017","unstructured":"Franco P, Ragona R, Arcadipane F, Mistrangelo M, Cassoni P, Rondi N, et al. Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer. Clin Transl Oncol. 2017;19(1):67\u201375.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"1019_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/COC.0000000000000009","volume":"39","author":"JA Call","year":"2016","unstructured":"Call JA, Prendergast BM, Jensen LG, Ord CB, Goodman KA, Jacob R, et al. Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study. Am J Clin Oncol. 2016;39(1):8-12. doi:10.1097\/COC.0000000000000009.\u00a0","journal-title":"Am J Clin Oncol"},{"key":"1019_CR8","doi-asserted-by":"crossref","unstructured":"Franco P, Arcadipane F, Ragona R, Mistrangelo M, Cassoni P, Munoz F, et al. Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients. Br J Radiol. 2016;89(1060):20150832. doi:10.1259\/bjr.20150832","DOI":"10.1259\/bjr.20150832"},{"issue":"1","key":"1019_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13014-018-1124-9","volume":"13","author":"P Franco","year":"2018","unstructured":"Franco P, De Bari B, Arcadipane F, Lepinoy A, Ceccarelli M, Furfaro G, et al. Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study. Radiat Oncol. 2018;13(1):172.","journal-title":"Radiat Oncol"},{"issue":"1","key":"1019_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000071200","volume":"65","author":"R Graf","year":"2003","unstructured":"Graf R, Wust P, Hildebrandt B, G\u00f6gler H, Ullrich R, Herrmann R, et al. Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology. 2003;65(1):14\u201322.","journal-title":"Oncology"},{"key":"1019_CR11","doi-asserted-by":"publisher","unstructured":"Katsochi D. Radiation therapy with a simultaneous integrated boost. In: Onal C, editor. Radiotherapy [Internet]. Rijeka: IntechOpen; 2017. Available from\u00a0https:\/\/doi.org\/10.5772\/67326.","DOI":"10.5772\/67326"},{"key":"1019_CR12","doi-asserted-by":"publisher","unstructured":"Dahl O, Myklebust MP, Dale JE, Leon O, Serup-Hansen E, Jakobsen A, et al. Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version. Acta Oncol (Madr) [Internet]. 2020;59(9):1016\u201323. Available from\u00a0https:\/\/doi.org\/10.1080\/0284186X.2020.1778180.","DOI":"10.1080\/0284186X.2020.1778180"},{"issue":"1","key":"1019_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","volume":"86","author":"LA Kachnic","year":"2013","unstructured":"Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, et al. RTOG 0529: A phase II evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys. 2013;86(1):27\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1019_CR14","doi-asserted-by":"publisher","unstructured":"Glynne-Jones R, Tan D, Hughes R, Hoskin P. Progress in radiotherapy treatment. Nat Publ Gr [Internet]. 2016;13(7):447\u201359. Available from\u00a0https:\/\/doi.org\/10.1038\/nrclinonc.2015.218.","DOI":"10.1038\/nrclinonc.2015.218"},{"issue":"5","key":"1019_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/BF02555448","volume":"30","author":"J Papillon","year":"1987","unstructured":"Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal - A series of 276 cases. Dis Colon Rectum. 1987;30(5):324\u201333.","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"1019_CR16","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"BH Bartelink","year":"1997","unstructured":"Bartelink BH, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer radiotherapy and gastro. J Clin Oncol. 1997;15(5):2040\u20139.","journal-title":"J Clin Oncol"},{"key":"1019_CR17","doi-asserted-by":"crossref","unstructured":"Party UACTW. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet. 1996;348:1049\u201354.","DOI":"10.1016\/S0140-6736(96)03409-5"},{"key":"1019_CR18","doi-asserted-by":"publisher","unstructured":"Northover J, Glynne-Jones R, Sebag-Montefiore D, James R, Meadows H, Wan S, et al. Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer [Internet]. 2010;102(7):1123\u20138. Available from\u00a0https:\/\/doi.org\/10.1038\/sj.bjc.6605605.","DOI":"10.1038\/sj.bjc.6605605"},{"key":"1019_CR19","doi-asserted-by":"crossref","unstructured":"Bosset JF, Roelofsen F, Morgan DAL, Budach V, Coucke P, Jager JJ, et al. Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups. Eur J Cancer. 2003;39(1):45\u201351.","DOI":"10.1016\/S0959-8049(02)00377-5"},{"key":"1019_CR20","doi-asserted-by":"crossref","unstructured":"Ben-Josef E, Moughan J, Ajani JA, Flam M, Gunderson L, Pollock JD, et al. Impact of overall treatment time on survival and local control in patients with anal cancer: a pooled data analysis of radiation therapy oncology group trials 87-04 and 98-11. J Clin Oncol. 2010;28(34):5061\u20136.","DOI":"10.1200\/JCO.2010.29.1351"},{"key":"1019_CR21","doi-asserted-by":"crossref","unstructured":"Chuong MD, Freilich JM, Hoffe SE, Fulp W, Weber JM, Almhanna K, et al. Intensity-modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal. Gastrointest Cancer Res. 2013;6(2):39\u201345.","DOI":"10.1200\/jco.2013.31.4_suppl.494"},{"issue":"5","key":"1019_CR22","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.ijrobp.2009.09.046","volume":"78","author":"JM Pepek","year":"2010","unstructured":"Pepek JM, Willett CG, Wu QJ, Yoo S, Clough RW, Czito BG. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys. 2010;78(5):1413\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1019_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijrobp.2007.12.027","volume":"72","author":"A Konski","year":"2008","unstructured":"Konski A, Garcia M, John M, Krieg R, Pinover W, Myerson R, et al. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92\u201308. Int J Radiat Oncol Biol Phys. 2008;72(1):114\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1019_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijrobp.2010.09.030","volume":"82","author":"LA Kachnic","year":"2012","unstructured":"Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, et al. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys. 2012;82(1):153\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"1019_CR25","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","volume":"14","author":"BM Flam","year":"1996","unstructured":"Flam BM, John M, Paajk TF, Petrelli N, Myerson R, Doggett S, et al. Role of mytomicin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol. 1996;14(9):2527\u201339.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01019-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-024-01019-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01019-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T01:07:07Z","timestamp":1718845627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-024-01019-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1007\/s12029-024-01019-5","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"10 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}